Long-term outcomes of Aripiprazole long-acting injectable: a 10-year mirror image study of patient acceptability and treatment effectiveness
Abstract Relapses are frequent in schizophrenia and other psychotic disorders. While long-acting injectable antipsychotics (LAIs) are effective in preventing hospital admissions and improving adherence and patient outcomes, they are still under-utilised. Furthermore, evidence from newer formulations...
Saved in:
Main Authors: | Joshua Barnett, Sofia Pappa |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-06-01
|
Series: | Schizophrenia |
Online Access: | https://doi.org/10.1038/s41537-025-00637-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate
by: Tomasz Pietrzak, et al.
Published: (2025-06-01) -
Procyclidine Use with Long-Acting Injectable Antipsychotics
by: Prabin Gautam, et al.
Published: (2025-06-01) -
Procyclidine Use in Long-Acting Injectable Antipsychotics
by: Shalina Mitchell, et al.
Published: (2025-06-01) -
Preparation and Evaluation of Long-Acting Injectable Levocetirizine Prodrug Formulation
by: Jun-hyun Ahn
Published: (2025-06-01) -
Long-Acting Antipsychotic Injections: Prescribing Practices Across BCUHB
by: Laura Robbins, et al.
Published: (2025-06-01)